10
Explore insightful resources that include videos, whitepapers, eBooks, application notes and more
This poster highlights how mosquito HV genomics has been used to automate the Illumina Nextera XT protocol at SEQ-IT, achieving 5X miniaturized reaction volumes while delivering reproducible, high-quality libraries. This miniaturized method was developed to identify and screen mutations with oncogenic potential and drug resistance (HIV, HBV, HCV), SNP detection, as well as in HLA-typing, among other applications.
Read moreUsing dedicated software and automation, Artios have developed in-house compound management for Design-Make-Test-Analyze processing and assay-ready plate generation. This results in: - Increased sample and data integrity through audited and trackable processes - Reduced cycle times and cost - Faster data reporting for better decision making and use of resources
Read moreWe demonstrate that the Roche KAPA EvoPlus V2 and KAPA EvoPlus V2 PCR-free DNA library preparation workflows can be successfully automated on firefly to create Illumina-compatible NGS libraries comparable to those prepared manually. The combination of these technologies enables significant time savings in the laboratory for whole genome sequencing applications, whilst also reducing operator variability.
Read moreHear from researchers from McGill University, as they present case studies in optimizing and advancing efficient workflows that couple in vitro exposures with ultraplexed library preparation using the QIAseq UPXome RNA Library Kit. This approach has increased the throughput of differential expression and dose-response analysis for tPODs derivation.
Read moreIn this webinar, Alex Rimmer, Samuel East, and Catriona Jamieson discuss how they used automation and Design of Experiments (DoE) approaches to drive the development of low-cost, animal-free media, and optimize cost-effective RNA delivery.
Read moreEditCo sought an automated solution for their inventory management to store a large library of oligonucleotides, specifically guide RNAs for gene editing mediated by programmable nucleases. The required rate and volume of sample retrieval and reformatting meant that manual operation with lab technicians simply wasn’t feasible.
Read moreIn this webinar, Marcella Ferrero, automation scientist at Camena, discussed the approach of developing a novel approach to DNA synthesis, which combines TdT-free enzyme-based technology with strategic use of automated liquid handling and how it can enable the next generation of therapeutics while minimizing the environmental impact of vital research.
Read moreJoin Tim Cernak, Associate Professor at the University of Michigan, and Kamila Koprowska, mosquito® Product Manager at SPT Labtech, as they explore how positive displacement technology and low-volume liquid handling drive scale and throughput in medicinal chemistry.
Read moreWatch as firefly effortlessly streamlines workflows, reducing human error and increasing throughput. With its advanced technology and user-friendly interface, you can focus on your research while firefly takes care of the details. Discover the future of laboratory automation.
Read moreDesign, Make, Test and Analyse (DMTA) screening requires the generation of compound assay ready plates (ARP) – a process that can be slow, costly and resource intensive. Negative impact on project cycle times/resource burden. Using dedicated software and automation, we have developed in-house compound management (CM) for DMTA processing and plate generation: Audited and trackable process – increased sample/data integrity. Fully automated workflow for biochemical & cellular assays. Reduced cycle times/cost. Faster data reporting to drive decision making/more effective use of resources.
Read moreOrion, a global pharmaceutical company based in Finland, develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The Medicine Design department within Orion R&D has several synthesis laboratories spread across two floors of the Espoo Research Center. Around 30 chemists and research assistants work in the synthesis labs every day and are supported by a 5-person analytical group that performs chromatographic analyses and preparative purifications to support the day-to-day synthesis work.
Read moreOrion, a global pharmaceutical company based in Finland, develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The Medicine Design department within Orion R&D has several synthesis laboratories spread across two floors of the Espoo Research Center. Around 30 chemists and research assistants work in the synthesis labs every day and are supported by a 5-person analytical group that performs chromatographic analyses and preparative purifications to support the day-to-day synthesis work.
Read more